Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Switzerland

 

Mediclinic stock jumps after a strong six months

Mediclinic, the largest South African hospital group by revenue, saw its shares jump by 7.5% to 346.4p on Friday, after the company reported a “material recovery” in profit margins. This is above the groups previous 2021 high of 344.6p struck in June.
October 20, 2021

Builder of Swiss Covid system offers it free to World Health Organisation

Getting the over-75s and the immune-suppressed to the front of the queue in Switzerland and 18 of its 23 cantons was the task for Romain Boichat and his team at Soignez-Moi faced last winter. The urgency is shown by the pace. Given the go-ahead on December 23, 2020, the online booking system for mobile phones was up and running on January 4. But the official sign-off awarding the contract didn't arrive until March 31, 2021. Boichart is now keen to offer the software to developing countries and is offering it free to the World Health Organisation.
October 15, 2021

HBI 2021: Strict data laws threaten future provision in DACH

Strict, politically-driven, laws on the use of data in Germany means that the healthcare sector is struggling to equip itself sufficiently for the future demand of healthcare, delegates heard at HBI 2021 in a panel led by Stephan Rau, partner with McDermott, Will & Emery.
October 8, 2021

HBI 2021: How long will rehab be acute’s poorer brother?

Rehabilitation has often been seen as the low-margin, poor brother of acute care. Often underfunded and overlooked, a panel at HBI 2021 sensed that the tide is turning and that, at last, the benefits of this Cinderella sector are being appreciated.
October 7, 2021

Nordic launches a process for €2bn+ Veonet

Strong rumours reported by HBI back in July that Nordic Capital-backed ophthalmology group Veonet (including Germany's largest operator by revenue Ober Scharrer) would come to market before the autumn have been proven correct. HBI understands the group has launched a process, and a price tag of in excess of €2bn is expected.
September 9, 2021

EU dermatology M&A slows

Investors in the US are pouring money into dermatology, while EU markets remain far quieter. To find out where and why deals are – and aren’t - happening, we round up the latest news from the sector in Europe, including the UK dermatology consultant-led business Dermatology Partnership, Sweden’s leading dermatology provider Diagnostiskt Centrum Hud, and Dermatologikum Hamburg in Germany.
September 9, 2021

Small-mid market M&A round up

As expected, M&A deal flow slowed through August as bankers and executives headed out on summer vacations. HBI has caught up with the mid-to-small-cap deals you may have missed; featuring hospitals, ophthalmology, and homecare. 
September 2, 2021

US homecare tech specialist buys Home Instead

US-based homecare tech specialist Honor Technology has acquired Home Instead, the global leader of franchise homecare services. The deal creates a global homecare group worth more than $2.1 billion in homecare revenue.  HBI chats with sources including Home Instead's UK CEO to find out what the deal means for markets outside of the United States.
August 19, 2021

Payors throw money at mental health

Psychotherapy, a highly fragmented market across Europe, has historically been mostly private pay. Waves of pandemic-related mental health crises are now forcing payors to multiply budgets or add new tariffs in countries from Czechia to Switzerland. Where's the opportunity?
August 12, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us